SeaStar Medical

SeaStar Medical

Yahoo Finance • 15 days ago

SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Executive Officer - Eric SchlorffSenior Vice President of Commercial and Business Operations - Tim VaracekChief Medical Officer - Kevi... Full story

Yahoo Finance • 15 days ago

Seastar medical targets NEUTRALIZE-AKI enrollment completion around year-end or Q1 2027 as QUELIMMUNE adoption reaches 20 hospitals

Earnings Call Insights: SeaStar Medical Holding Corporation (ICU) Q2 2026 MANAGEMENT VIEW * "We are very pleased with our progress this quarter" and "Our pediatric AKI market penetration and continued strong QUELIMMUNE revenue growth b... Full story

Yahoo Finance • 21 days ago

SeaStar Medical to Report Second Quarter Financial Results on August 12, 2026

DENVER, Aug. 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss... Full story

Yahoo Finance • last month

SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)

Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment options DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: I... Full story

Yahoo Finance • 3 months ago

SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates

Added 7 top-rated children’s hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical tri... Full story

Yahoo Finance • 5 months ago

SeaStar Medical to Report Fourth Quarter and Year-End 2025 Financial Results on March 25, 2026

DENVER, March 18, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 5 months ago

Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are... Full story

Yahoo Finance • 8 months ago

SeaStar Medical Announces 1-for-10 Reverse Split

SeaStar Medical DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and pot... Full story

Yahoo Finance • 9 months ago

SeaStar Medical Announces FDA Approval of Reduction in Mandatory Enrollment for SAVE Surveillance Registry Evaluating QUELIMMUNE™ Safety for Pediatric AKI

FDA lowers surveillance requirement to 50 patients from 300 patients in original HDE approval based on assessment of first 21 SAVE Surveillance Registry patients Compelling efficacy data to date along with completion of registry expected... Full story

Yahoo Finance • 9 months ago

SeaStar Medical Announces Appointment of Michael Messinger as CFO

DENVER, Nov. 17, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 9 months ago

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Business highlights include: Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Commercial use of QUELIMMUNE therapy demonstrates positive survival results as reported from... Full story

Yahoo Finance • 10 months ago

SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025

DENVER, Nov. 05, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 11 months ago

SeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in Children

Data show results consistent with clinical trial experience A high level of safety – no device-related adverse events Strong survival data extending to 90 days DENVER, Sept. 29, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporati... Full story

Yahoo Finance • 11 months ago

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Independent DSMB reports zero device-related safety issues Supports potential clinical benefit Trial sample size re-estimated to strengthen statistical power DENVER, Sept. 24, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation... Full story

Yahoo Finance • 11 months ago

SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children

DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be presented by SeaSta... Full story

Yahoo Finance • 12 months ago

SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference

DENVER, Sept. 04, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • 12 months ago

SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival

DENVER, Sept. 02, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of... Full story

Yahoo Finance • last year

SeaStar Medical Holding GAAP EPS of -$0.18 beats by $0.25, revenue of $0.34M beats by $0.14M

* SeaStar Medical Holding press release [https://seekingalpha.com/pr/20200176-seastar-medical-reports-second-quarter-2025-financial-results-and-provides-business-updates] (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]): Q2 GAAP EPS of... Full story

Yahoo Finance • last year

SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates

Business highlights include: Adult NEUTRALIZE-AKI trial enrolls 31 new patients, now over 60% enrolledThree new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury (AKI)Positive survival re... Full story

Yahoo Finance • last year

SeaStar Medical files to sell 10.92M shares of common stock for holders

* SeaStar Medical (NASDAQ:ICU [https://seekingalpha.com/symbol/ICU]) filed to sell 10.92M shares of common stock for holders. * This preliminary prospectus is not an offer to sell. * Filing [https://seekingalpha.com/filing/10286537]... Full story